Home
About Us
Contact Us

Search the Site





About CF
Living with CF
Updates from the Team
Download Center
Pharmaceutical Updates
In Their Own Words
Important Links
Insurance Information
Clinical Trials

Cystic Fibrosis Care Center
doctor and nurses Check here regularly for news from the North Shore-LIJ/Cohen Children's Medical Center Cystic Fibrosis Center team.

We are reviewing the new CF infection control guidelines, and will be implanting the changes over the next two months. You may see some changes in our outpatient and inpatient settings. These new procedures are being undertaken to provide you with the best care possible. To review the new guidelines, please visit cff.org.

Team Announcements


CF CENTER HOLDS MEET AND GREET NIGHTS
The CF center will hold MEET and GREET nights for parents of people with CF who are 16 to 17 years old and presently being followed by pediatric CF. These meetings will take place throughout the upcoming year and are a chance for parents to meet with the adult and pediatric teams before transferring care to the adult side. The next meet and greet will be held on Thursday, September 25, 2014 at the Adult Center, 410 Lakeville Rd, Suite 104, New Hyde Park, NY 11040. Look for more announcements.

FDA approves TOBI Podhaler to treat a type of bacterial lung infection in cystic fibrosis patients
The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.

Cystic fibrosis is a genetic disease that affects about 30,000 pediatric and adult patients in the United States. Cystic fibrosis causes the body to produce thick, sticky mucus that builds up in the lungs and blocks airways. The buildup of mucus makes it easy for bacteria like P. aeruginosa to grow and cause a chronic lung infection that, over time, can severely damage the lungs. Many patients with cystic fibrosis are treated with antibiotics using a nebulizer machine.

TOBI Podhaler, a plastic, handheld inhaler device, contains a dry powder formulation of tobramycin, an antibiotic used to treat P. aeruginosa infection. The powder is inhaled twice daily using the Podhaler device for 28 days. Patients should then stop TOBI Podhaler therapy for 28 days before resuming again.

"Today's approval broadens the available delivery mechanism options for patients with cystic fibrosis who require treatment for P. aeruginosa," said Edward Cox, M.D., M.P.H, director of the Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research. "This product is the first dry powder antibacterial drug delivered with a handheld dry powder inhaler."

TOBI Podhaler's effectiveness was established in a study of 95 pediatric and adult patients with cystic fibrosis. All patients were 6 years of age or older and infected with P. aeruginosa. Patients were randomly assigned to receive TOBI Podhaler or a placebo for the first 28 days of the study. All patients then received treatment with TOBI Podhaler for the remainder of the study.

The study was designed to determine the improvement in lung function by measuring the change in forced expiratory volume in one second (FEV1). Patients treated with TOBI Podhaler experienced a statistically significant increase of 12.5 percent in FEV1 compared to 0.09 percent in patients treated with placebo. Additional data supporting safety and effectiveness were available from other studies enrolling 487 patients.

Common side effects reported in patients treated with TOBI Podhaler during the clinical studies included cough, including a cough that produces phlegm or mucus; coughing up of blood (hemoptysis); lung disorder; shortness of breath; fever; mouth and throat pain; changes in voice volume or quality (dysphonia); and headache.

TOBI Podhaler is marketed by East Hanover, N.J.-based Novartis.

For more information:

FDA Approved Drugs: Questions and Answers

NIH: Cystic Fibrosis



Listen to Dr. Germana on
Dr. Joan Germana was interviewed on Island Outlook for the Long Island Radio Group. The interview aired on WHLI, WKJY, WBZO and WIGZ on April 29, 2012.




Steven and Alexandra Cohen Children’s Center/Long Island Jewish Medical Center honored at the North American Cystic Fibrosis Conference.
Steven and Alexandra Cohen Children's Center/Long Island Jewish Medical Center was honored at the North American Cystic Fibrosis Conference, being named one of eleven centers to earn the 2010-2011 Quality Care Award. These awards honor centers that excel at the following quality improvement performance standards: Award
  • Actively uses clinical outcomes data to identify opportunities for improvement and documents results of improvement efforts.
  • Aligns improvement efforts to result in measurable improvement in important clinical outcomes.
  • Consistently and actively involves patients and families in identifying, designing and/or implementing improvement efforts.
  • Employs innovative strategies to improve care processes and outcomes.
  • Implements system changes that result in high reliability of care processes.
Learn more at the News and Events section on the CF Foundation's website. You can read the full article in the CFF Winter Highlights newsletter, here.




Patient Assistance Resource Library


To help you navigate the complex world of health insurance and healthcare coverage, the CFF Patient Assistance Resource Library (http://www.cff.org/LivingWithCF/AssistanceResources/Library/) offers a range of useful information, including:
  • Sample letters of medical necessity and prior authorization;
  • How-to guides to navigating common insurance obstacles;
  • Templates for insurance appeals, exceptions and reconsiderations;
  • CF care guidelines;
  • Evidence-based medical journal articles; and
  • White papers for medical professionals.


Mother of CF Patient Receives Prestigious Recognition
Maryann O'Mahony is the recipient of 2010 Long Island MVP award from the Greater New York Chapter of the Cystic Fibrosis Foundation. Many thanks to Maryann for her tremendous work in CF, and congratulations on this well-deserved recognition.




© 2014 Cystic Fibrosis Care Center | 410 Lakeville Rd, Suite 107 Lake Success, NY 11042 | 516-465-5400 | All Rights Reserved | Disclaimer | Site Map | Site by PriMedia